Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma.
about
Efficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma.Allergic rhinitis: evidence for impact on asthmaA high-throughput liquid chromatography tandem mass spectrometry method for the comparative determination of fluticasone propionate by reversed-phase liquid chromatography and capillary electrophoresis methods in pharmaceutical nasal sprays.Hay fever in adolescents and adults.Managing co-morbid asthma with allergic rhinitis: targeting the one-airway with leukotriene receptor antagonists.Asthma in patients with Japanese cedar pollinosis.The Saudi initiative for asthma - 2012 update: Guidelines for the diagnosis and management of asthma in adults and childrenAllergic rhinitis and its impact on otorhinolaryngology.The Saudi Initiative for Asthma - 2016 update: Guidelines for the diagnosis and management of asthma in adults and children.Rhinitis patients with sputum eosinophilia show decreased lung function in the absence of airway hyperresponsiveness.Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN.The united allergic airway: connections between allergic rhinitis, asthma, and chronic sinusitis.Impact of comorbidities on asthma.The investigation of severe asthma to define phenotypes.Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis.Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyond.Pathogenesis of rhinitis.Severe Persistent Allergic Rhinitis. Inflammation but No Histologic Features of Structural Upper Airway Remodeling.Prevalence of sinusitis and efficacy of intranasal corticosteroid treatment on asthmatic symptoms in asthmatic patients with rhinosinusitis: a pilot study.Lack of control of severe asthma is associated with co-existence of moderate-to-severe rhinitis.Comorbid "treatable traits" in difficult asthma: Current evidence and clinical evaluation.Sublingual immunotherapy tablets as a disease-modifying add-on treatment option to pharmacotherapy for allergic rhinitis and asthma.Effect of an intranasal corticosteroid on exercise induced bronchoconstriction in asthmatic children.
P2860
Q30360466-7F192F49-D2E9-4427-AA54-2B9DB3C9C085Q33265228-BB80B8FE-B478-4D59-A853-D645B0B428C3Q33444404-88D7B770-D04C-4F20-8AA4-6F560EE9F3F6Q33949990-26AC2A07-410A-4733-8BA6-6D444920D0CAQ36371018-C70A5C98-0EF1-43DE-929E-0B9C21EE5A42Q36371023-805C8944-3FC8-42D0-B532-73D69B277F12Q36422663-C7B6BF61-7150-4E00-BBB8-BCD0C9FFEB32Q36469365-EF1C55F2-49CB-430E-B4BA-917880AAC41AQ36566081-EFA98D97-2B62-4B92-9E46-A64C18CCE223Q36962215-B093821B-4444-43DE-B002-440499768BBDQ36966123-4420414A-D521-48CC-97B1-3DDB63437742Q37530852-AED280FE-FEBF-4247-99F1-2F9BB5D98328Q37754787-8BD755D6-0D17-4A69-B10E-890520F2687FQ38003661-39249A69-4DDC-4998-B45E-CD1A1EED9417Q38099379-30F831FB-41F4-46FB-BB15-E131963F3DBAQ38205858-64E010DD-2E44-4611-B922-BD194B6274AFQ38902173-BC296137-7802-47C4-84F3-C38A2881D024Q40530800-D522654F-D7F3-474F-9D03-43B01228E4B1Q41083351-2F0F63BC-6261-4125-8E85-BE558890EC48Q45383676-EB7F49DD-CAF9-4B13-95E2-E549F5CD7DDFQ47659621-51D143E3-C991-4876-8904-67B5EA20EE21Q47943200-3D1598CA-B184-4705-8D02-0B2A8271EA7FQ48518713-1131BF66-7EAB-43D0-B5D0-58208BBF8C8A
P2860
Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma.
@en
Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma.
@nl
type
label
Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma.
@en
Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma.
@nl
prefLabel
Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma.
@en
Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma.
@nl
P2093
P2860
P1433
P1476
Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma.
@en
P2093
D H Richards
L P Nielsen
M Williams
P Cauwenberge
P2860
P304
P356
10.1111/J.1398-9995.2005.00819.X
P577
2005-07-01T00:00:00Z